Four Translational Research Awards headed by GRU Cancer Center clinical and scientific collaborators were selected for funding. The four winning projects were selected by an eight-member committee from among 27 submissions.
▪ Yukai He, MD, PhD, Edward J. Kruse, DO, FACS, and Todd D. Merchen, MD: “Activating hAFP and hGPC3 specific immune responses to prevent HCC.”
▪ Kebin Liu, PhD, Asha Nayak-Kapoor, MD, and Wendy Bollag, PhD, FAHA: “Apoptosis resistance and MDSC persistence in CRC Patients.”
▪ Mingqiang (Ming) Ren, PhD, and Vamsi Kota, MD: “Molecular targeting therapy of AML by ponatinib.”
▪ Huidong Shi, PhD, and Farrukh T. Awan, MD: “Targeting PI3K/mTOR signaling in treatment of chronic lymphocytic leukemia.”